Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir?
R
R
de la Cámara
J M
JM
Fernández-Rañada
D000212:Acyclovir / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000008:administration & dosage*; D006801:Humans; D011292:Premedication; D014184:Transplantation, Homologous
D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir